Article Text

Download PDFPDF

Correction: Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1- immunotherapy in colon cancer

Statistics from Altmetric.com

Ghonim MA, Ibba SV, Tarhuni AF, et al. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J Immunotherapy Cancer 2021;9:e001643. doi: 10.1136/jitc-2020-001643

This paper has been updated to revise author affiliations and funding details.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.